过氧化物酶体增殖物激活受体γ与消化系肿瘤
摘要
过氧化物酶体增殖物激活受体 (PPARγ)属于核激素受体超家族中的一员 ,在调控肿瘤细胞的生长、分化及凋亡等方面起重要作用。食管癌、胃癌、大肠癌、胰腺癌和肝癌中PPARγ表达增加。PPARγ的合成丝体曲格列酮等可抑制肿瘤细胞的生长 。
出处
《国外医学（生理病理科学与临床分册）》
2002年第5期470-472,共3页
Foreign Medical Sciences(Pathophysiology and Clinical Medicine)
参考文献25
-
1Mueller E, Sarraf P, Tontononz P, et al. Terminal differentiation of human breast cancer through PPAR gamma[J]. Mol Cell, 1998,1(3):465- 470.
-
2Sarraf P, Mueller E, Jones D, et al. Differentiation and reversal of malignant changes in colon cancer through PPARgamma [J]. Nat Med,1998,4(9): 1046 - 1052.
-
3Vamecq J, Latruffe N. Medical significance of peroxisome prolfferatoractivated receptors[J]. Lancet, 1999,354(9173): 141 - 148.
-
4Fajas L, Auboeuf D, Raspe E, et al. The organization, promoter analysis, and expression of the human PPARgamma gene[J]. FEBS Lett,1998,438(1 - 2) :55 - 60.
-
5Palakurthi SS, Aktas H, Grubissich LM, et al. Anticancer effects of thiazolidinediones are independent of peroxisome prolfferator- activated receptor gamma and mediated by inhibition of translation initiation [J].Cancer Res, 2001,61(16):6213-6218.
-
6Young PW, Buckle DR, Cantello BC, et al. Identification of high - affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653)in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator- activated receptor gamma[J] .J Pharmacol Exp Ther,1998,284(2) :751 - 759.
-
7Henke BR, Blanchard SG, Brackeen MF, et al. N - (2- Benzoylphenyl) - L- tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents [J]. J Med Chem, 1998,41(25):5020-5036.
-
8Collins JL, Blanchard SG, Boswell GE, et al. N- (2- Benzoylphenyl)- L - tyrosine PPARgamma agonists. 2. Structure - activity relationship and optimization of the Phenyl alkyl ether moiety [J]. J Med Chem,1998,41 (25) :5037 - 5054.
-
9Berger J, Leibowitz MD, Doebber TW, et al. Novel peroxisome proliferator- activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects [J]. J Biol Chem, 1999, 274 (10): 6718 -6725.
-
10Kliewer SA, Sundseth SS, Jones SA, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma[J]. Proc Natl Acad Sci USA, 1997,94(9) :4318 - 4323.
-
1杨雪,韩盛玺.过氧化物酶体增殖物激活受体γ与胃肠肿瘤研究进展[J].国际消化病杂志,2006,26(1):55-57.
-
2程文,程南生.PPAR-γ及其配体在消化系统肿瘤中作用机制的研究进展[J].国外医学（外科学分册）,2005,32(3):200-204. 被引量：2
-
3陈豫民,王琰,韩轲.bcl-2结合抗凋亡蛋白在食管癌中的表达及意义[J].山西医药杂志,2015,44(16):1873-1875. 被引量：4
-
4唐琛.PPARγ在卵巢癌中的研究进展[J].赣南医学院学报,2009,29(3):477-480. 被引量：1
-
5何坤,胡泽民.PPARγ在肝癌中的研究进展[J].岭南现代临床外科,2006,6(5):332-334.
-
6王涛,王绩英.PPAR-γ抗肿瘤机制的研究新进展[J].山东医药,2011,51(32):112-113.
-
7夏启松,修瑞娟,孙仁宇.过氧化物酶体增殖物激活受体γ途径抑制肿瘤血管生成的研究进展[J].肿瘤防治研究,2009,36(5):443-447.
-
8曹春晓(综述),王玉华(审校).PPARγ及罗格列酮与消化系统肿瘤[J].实用肿瘤学杂志,2009,23(6):579-581. 被引量：4
-
9袁婕,石巍.过氧化物酶增殖活化受体-γ与胃癌的相关性研究进展[J].社区医学杂志,2013,11(2):68-69.
-
10王娟,胡志前.肝细胞核因子4α在消化系统肿瘤中的研究[J].国际肿瘤学杂志,2014,41(12):915-918.
